NuCana Granted U.S. Patent #11925658 Today For "Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance". Broad Patent For Leukemia, Prostate, Lung, And Breast Cancers.
Benzinga Newsdesk - Mar 12, 2024, 4:00PM